8-K

HeartCore Enterprises, Inc. (HTCR)

8-K 2023-11-13 For: 2023-11-13
View Original
Added on April 07, 2026

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of

the

Securities Exchange Act of 1934

Dateof report (Date of earliest event reported): November13, 2023

HEARTCORE

ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

Delaware 001-41272 87-0913420
(State<br> or other jurisdiction<br><br> <br>of<br> incorporation) (Commission<br><br> <br>File<br> Number) (I.R.S.<br> Employer<br><br> <br>Identification<br> Number)

1-2-33

,Higashigotanda ,Shinagawa-ku ,Tokyo ,Japan

(Address of principal executive offices)

+81-3-6409-6966

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title<br> of each class Trading<br> Symbol(s) Name<br> of each exchange on which registered
Common<br> Stock HTCR Nasdaq<br> Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item2.02. Results of Operations and Financial Condition.

On November 13, 2023, HeartCore Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine months ended September 30, 2023. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in any website is not a part of this Current Report on Form 8-K.

The information included in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit<br><br> <br>No. Description
99.1 Press<br> release of the registrant issued November 13, 2023.
104 Cover<br> Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HEARTCORE ENTERPRISES, INC.
Dated:<br> November 13, 2023 By: /s/ Sumitaka Yamamoto
Name: Sumitaka<br> Yamamoto
Title: Chief<br> Executive Officer

Exhibit99.1



HeartCoreReports Third Quarter 2023 Financial Results

NEWYORK and TOKYO, November 13, 2023 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “theCompany”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the third quarter ended September 30, 2023.

ThirdQuarter 2023 and Recent Operational Highlights

Q3<br> 2023 Revenue of $4.7 million, 150% higher than Q3 2022.
Enterprise<br> software revenue doubled compared to Q3 2022.
Consulting<br> services revenues were only approximately $612,000, as client IPOs have been moved to Q4<br> 2023.
Year-to-Date<br> 2023 revenue of $18.5 million, 172% higher than Q3 2022.
Year-to-Date<br> 2023 Net Loss of $1.8 million, or $(0.07) per share.
Launched<br> its digital experience platform, Daishiwake platform into the U.S. and Japanese markets.
Awarded<br> top market share (15%) in Japan for its CMS platform for eight consecutive years.
Signed<br> eleventh Go IPO contract with GATES GROUP Inc.
Hired<br> the New York-based sales team of Sabatini Global, further augmenting the Company’s<br> headcount in the U.S.
Hosted<br> Nasdaq Listing Guidance seminar for Japanese companies as part of the Company’s<br> Go IPO business development efforts.
Engaged<br> licensing agreement with Marushin Corporation for CONTROLIO software.
Partnered<br> with INTRIX, Inc. to license HeartCore’s Content Management System (CMS).

ManagementCommentary

“HeartCore’s transformation continued in the third quarter, as we made progress across all facets of our business operations,” said CEO Sumitaka Kanno Yamamoto. “In October, our Content Management System (CMS) platform was awarded as the solution with top market share in Japan for the eighth consecutive year by ITR Corporation, an independent IT consulting research firm. As the market leader in Japan, we are now focused on growing our global footprint. Our acquisition of Sigmaways and the hiring of the New York-based sales team of Sabatini Global provides talented individuals and new technologies to expand our business in the dynamic U.S. market.

“The second and third quarters of 2023 did not turn out exactly like we expected for our consulting service clients, as the IPO market was turbulent, and markets were faced with rising interest rates and economic uncertainty. During the first nine months of 2023, we generated $6.4 million in revenue, primarily from valuation of warrants from our GO IPO consulting services business. Nearly all of that, over $5 million, occurred in the first quarter 2023 when two of our clients launched their IPOs. We have entered into consulting agreements with 11 companies to assist them in their IPO process. With two of them across the finish line and three more companies slated to IPO soon, we anticipate this segment of the business to be a vital growth engine for our organization that will drive significant revenue growth and add value to our balance sheet in the coming quarters.”

ThirdQuarter 2023 Financial Results

Revenues increased 150.4% to $4.7 million compared to $1.9 million in the same period last year. The increase was primarily due to increased revenue from customized software development and services as a result of the acquisition of Sigmaways and its subsidiaries, and an increase from Go IPO consulting services as the Company obtained more IPO consulting customers in 2023.

Gross profit increased 151.7% to $0.8 million from $0.3 million in the same period last year. The increase was primarily from increased maintenance and support services, customized software development and services, and Go IPO consulting services.

Operating expenses increased to $2.6 million from $2.3 million in the same period last year. The increase was primarily due to general and administrative expenses and research and development expenses, slightly offset by decreases in selling expenses.

Net loss was $2.5 million or $(0.11) per diluted share, compared to a net loss of $2.0 million or $(0.11) per diluted share, in the same period last year.

As of September 30, 2023, the Company had cash and cash equivalents of $2.2 million compared to $7.2 million in December 31, 2022.

NineMonths 2023 Financial Results

Revenues increased 171.6% to $18.5 million compared to $6.8 million in the same period last year. The increase was primarily due to an increase in Go IPO consulting service revenues and received warrants from customers, and an increase from customized software development and services as a result of Sigmaways and its subsidiaries.

Gross profit increased 176.5% to $8.0 million from $2.9 million in the same period last year. The increase was primarily due to an increase in Go IPO consulting service revenues and received warrants from customers, and an increase from customized software development and services as a result of Sigmaways and its subsidiaries.

Operating expenses increased to $8.9 million from $8.1 million in the same period last year. The increase was primarily due to increases in general and administrative expenses, offset by a decrease in selling expense, and research and development expenses.

Net loss was about $1.8 million or $(0.07) per diluted share compared to a net loss of $5.3 million or $(0.29) per diluted share, in the same period last year.

AboutHeartCore Enterprises, Inc.

Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPO^SM^ consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company’s products and services is available at and https://heartcore-enterprises.com/.



Forward-LookingStatements

All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCoreInvestor Relations Contact:

Gateway Group, Inc.

Matt Glover and John Yi

HTCR@gateway-grp.com

(949) 574-3860



HeartCore Enterprises, Inc.

UnauditedConsolidated Statements of Operations and Comprehensive Loss

For the nine months ended<br><br> September 30, For the three months ended<br><br> September 30,
2023 2022 2023 2022
Revenues $ 18,518,431 $ 6,818,774 $ 4,688,908 $ 1,872,476
Cost of revenues 10,548,245 3,935,908 3,860,241 1,543,256
Gross profit 7,970,186 2,882,866 828,667 329,220
Operating expenses:
Selling expenses 1,330,747 1,706,250 274,043 771,496
General and administrative expenses 7,305,392 5,832,276 2,172,298 1,513,028
Research and development expenses 289,303 583,762 170,071 58,275
Total operating expenses 8,925,442 8,122,288 2,616,412 2,342,799
Loss from operations (955,256 ) (5,239,422 ) (1,787,745 ) (2,013,579 )
Other income (expenses):
Changes in fair value of investments in marketable securities (500,762 ) - (271,740 ) -
Changes in fair value of investments in warrants (294,565 ) - (460,672 ) -
Interest income 64,633 32,256 14,363 21,707
Interest expenses (125,073 ) (39,361 ) (42,619 ) (10,500 )
Other income 176,641 40,645 52,640 15,195
Other expenses (62,701 ) (58,050 ) (25,947 ) (2,826 )
Total other income (expenses) (741,827 ) (24,510 ) (733,975 ) 23,576
Loss before income tax provision (1,697,083 ) (5,263,932 ) (2,521,720 ) (1,990,003 )
Income tax expense (benefit) 58,859 (10,906 ) 19,413 (19,069 )
Net loss (1,755,942 ) (5,253,026 ) (2,541,133 ) (1,970,934 )
Less: net loss attributable to non-controlling interest (419,211 ) - (233,913 ) -
Net loss attributable to HeartCore Enterprises, Inc. $ (1,336,731 ) $ (5,253,026 ) $ (2,307,220 ) $ (1,970,934 )
Other comprehensive income (loss):
Foreign currency translation adjustment (85,244 ) 428,118 (90,743 ) 128,705
Total comprehensive loss (1,841,186 ) (4,824,908 ) (2,631,876 ) (1,842,229 )
Less: comprehensive loss attributable to non-controlling interest (422,352 ) - (235,094 ) -
Comprehensive loss attributable to HeartCore Enterprises, Inc. $ (1,418,834 ) $ (4,824,908 ) $ (2,396,782 ) $ (1,842,229 )
Net loss per common share attributable to HeartCore Enterprises, Inc.
Basic $ (0.07 ) $ (0.29 ) $ (0.11 ) $ (0.11 )
Diluted $ (0.07 ) $ (0.29 ) $ (0.11 ) $ (0.11 )
Weighted average common shares outstanding
Basic 20,257,020 18,014,483 20,842,690 17,835,027
Diluted 20,257,020 18,014,483 20,842,690 17,835,027

The accompanying notes are an integral part of these unaudited consolidated financial statements.



HeartCore Enterprises, Inc.

ConsolidatedBalance Sheets

December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents 2,199,565 $ 7,177,326
Accounts receivable 2,562,239 551,064
Investments in marketable securities 757,106 -
Prepaid expenses 683,327 538,230
Note receivable 300,000 -
Current portion of long-term note receivable 100,000 -
Due from related party 42,439 48,447
Other current assets 111,326 220,070
Total current assets 6,756,002 8,535,137
Non-current assets:
Property and equipment, net 752,940 203,627
Operating lease right-of-use assets 2,413,814 2,644,957
Intangible asset, net 4,675,000 -
Goodwill 3,276,441 -
Long-term investments in warrants 2,456,902 -
Long-term note receivable 200,000 -
Deferred tax assets 222,172 263,339
Security deposits 338,220 244,395
Long-term loan receivable from related party 184,076 246,472
Other non-current assets 67 661
Total non-current assets 14,519,632 3,603,451
Total assets 21,275,634 $ 12,138,588
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses 1,779,953 $ 497,742
Accrued payroll and other employee costs 558,394 360,222
Due to related party 7,859 402
Current portion of long-term debts 525,440 697,877
Insurance premium financing 122,279 -
Factoring liability 217,250 -
Operating lease liabilities, current 365,241 291,863
Finance lease liabilities, current 17,076 19,294
Income tax payables 103,935 2,747
Deferred revenue 1,740,877 1,724,519
Other current liabilities 222,089 53,027
Total current liabilities 5,660,393 3,647,693
Non-current liabilities:
Long-term debts 1,351,830 1,123,735
Operating lease liabilities, non-current 2,113,917 2,421,054
Finance lease liabilities, non-current 68,535 459
Deferred tax liabilities 1,309,000 -
Other non-current liabilities 197,817 138,018
Total non-current liabilities 5,041,099 3,683,266
Total liabilities 10,701,492 7,330,959
Shareholders’ equity:
Preferred shares (0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively) - -
Common shares (0.0001 par value, 200,000,000 shares authorized; 20,842,690 and 17,649,886 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively) 2,083 1,764
Additional paid-in capital 19,431,987 15,014,607
Accumulated deficit (11,910,310 ) (10,573,579 )
Accumulated other comprehensive income 282,734 364,837
Total HeartCore Enterprises, Inc. shareholders’ equity 7,806,494 4,807,629
Non-controlling interest 2,767,648 -
Total shareholders’ equity 10,574,142 4,807,629
Total liabilities and shareholders’ equity 21,275,634 $ 12,138,588

All values are in US Dollars.

The accompanying notes are an integral part of these unaudited consolidated financial statements.

HeartCore Enterprises, Inc.

UnauditedConsolidated Statements of Cash Flows

For the nine months ended September 30,
2023 2022
Cash flows from operating activities
Net loss $ (1,755,942 ) $ (5,253,026 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expenses 495,200 64,398
Gain on disposal of property and equipment (4,737 ) -
Amortization of debt issuance costs 2,257 3,051
Non-cash lease expense 254,876 207,549
Loss on termination of lease 76 -
Deferred income taxes (109,690 ) (5,843 )
Stock-based compensation 1,267,699 1,225,477
Warrants received as noncash consideration (4,009,335 ) -
Changes in fair value of investments in marketable securities 500,762 -
Changes in fair value of investments in warrants 294,565 -
Changes in assets and liabilities:
Accounts receivable (322,583 ) 168,021
Prepaid expenses 187,269 (56,553 )
Other assets (23,982 ) (142,967 )
Accounts payable and accrued expenses 597,247 (96,238 )
Accrued payroll and other employee costs 7,471 59,059
Due to related party 7,562 3,098
Operating lease liabilities (231,499 ) (213,691 )
Finance lease liabilities - (370 )
Income tax payables 101,058 (7,704 )
Deferred revenue 200,256 45,938
Other liabilities 83,809 (206,569 )
Net cash flows used in operating activities (2,457,661 ) (4,206,370 )
Cash flows from investing activities
Purchases of property and equipment (516,658 ) (41,672 )
Proceeds from disposal of property and equipment 24,935 -
Advances on note receivable (600,000 ) -
Repayment of loan provided to related party 34,823 33,042
Payment for acquisition of subsidiary, net of cash acquired (724,910 ) -
Net cash flows used in investing activities (1,781,810 ) (8,630 )
Cash flows from financing activities
Proceeds from initial public offering, net of issuance cost - 13,602,554
Proceeds from issuance of common shares prior to initial public offering - 220,572
Repurchase of common shares - (3,500,000 )
Payments for finance leases (16,537 ) (29,051 )
Proceeds from long-term debt 219,427 258,087
Repayment of long-term debts (584,779 ) (699,407 )
Repayment of insurance premium financing (266,756 ) (298,886 )
Net proceeds from factoring arrangement 217,250 -
Payments for debt issuance costs (656 ) (1,030 )
Payment for mandatorily redeemable financial interest - (430,489 )
Net cash flows provided by (used in) financing activities (432,051 ) 9,122,350
Effect of exchange rate changes (306,239 ) (200,981 )
Net change in cash and cash equivalents (4,977,761 ) 4,706,369
Cash and cash equivalents - beginning of the period 7,177,326 3,136,839
Cash and cash equivalents - end of the period $ 2,199,565 $ 7,843,208
-
Supplemental cash flow disclosures:
Interest paid $ 59,290 $ 38,387
Income taxes paid $ 91,657 $ 3,013
Non-cash investing and financing transactions
Payroll withheld as repayment of loan receivable from employees $ - $ 12,034
Liabilities assumed in connection with purchase of property and equipment $ 9,602 $ 17,731
Share repurchase liability settled by issuance of common shares $ - $ 16
Operating lease right-of-use asset obtained in exchange for operating lease liability $ 317,040 $ -
Finance lease right-of-use asset obtained in exchange for finance lease liability $ 93,117 $ -
Remeasurement of operating lease liability and right-of-use asset due to lease modification 12,579 -
Deferred offering costs recognized against the proceeds from the offering $ - $ 178,847
Insurance premium financing $ 389,035 $ 388,538
Common shares issued for acquisition of subsidiary $ 3,150,000 $ -
Investments in warrants converted to marketable securities $ 1,257,868 $ -

The accompanying notes are an integral part of these unaudited consolidated financial statements.